7.33
+0.48(+7.01%)
Currency In USD
| Previous Close | 6.85 |
| Open | 7 |
| Day High | 7.5 |
| Day Low | 6.85 |
| 52-Week High | 1,200 |
| 52-Week Low | 5.37 |
| Volume | 52,928 |
| Average Volume | 401,463 |
| Market Cap | 55.39M |
| PE | 0 |
| EPS | -12,356.9 |
| Moving Average 50 Days | 7.11 |
| Moving Average 200 Days | 242.22 |
| Change | 0.48 |
If you invested $1000 in Helius Medical Technologies, Inc. (HSDT) 10 years ago, it would be worth $0 as of September 11, 2025 at a share price of $7.33. Whereas If you bought $1000 worth of Helius Medical Technologies, Inc. (HSDT) shares 5 years ago, it would be worth $0.01 as of September 11, 2025 at a share price of $7.33.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Helius Announces Positive Outcome of the Portable Neuromodulation Stimulator PoNS® Stroke Registrational Program and Upcoming Submission to FDA Under Breakthrough Designation
GlobeNewswire Inc.
Jul 21, 2025 11:00 AM GMT
NEWTOWN, Pa., July 21, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced positive outcome
Helius Medical Technologies, Inc. Compliant with Nasdaq’s Continued Listing Requirements
GlobeNewswire Inc.
Jul 09, 2025 12:30 PM GMT
NEWTOWN, Pa., July 09, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, toda
Helius Medical Technologies, Inc. Announces Claim Authorization by CignaHealth, for its Portable Neuromodulation Stimulator (PoNS®) Device
GlobeNewswire Inc.
Jun 16, 2025 11:00 AM GMT
- CignaHealth becomes fifth major payer to authorize claim for PoNS Device at out-of-network adjusted negotiated list price of $19,161- -This follows another recent authorization by Anthem Multiplan for PoNS Device at out-of-network negotiated price